[HTML][HTML] Pathogenesis of human adenomyosis: current understanding and its association with infertility

KN Khan, A Fujishita, T Mori - Journal of clinical medicine, 2022 - mdpi.com
The aim of this review article was to summarize our current understanding on the etiologies
and pathogenesis of human adenomyosis and to clarify the relative association between …

[HTML][HTML] Adenomyosis: diagnosis and management

S Schrager, L Yogendran, CM Marquez… - American Family …, 2022 - aafp.org
Adenomyosis is a clinical condition where endometrial glands are found in the myometrium
of the uterus. One in three patients with adenomyosis is asymptomatic, but the rest may …

Long-acting reversible contraceptives: new evidence to support clinical practice

S Pearson, CJ Boerma, K McNamee… - Australian Journal of …, 2022 - search.informit.org
Background: General practice plays a key role in providing access to contraceptive options
to reduce unintended pregnancies. The use of long-acting reversible contraceptives …

[HTML][HTML] Prevalence of adenomyosis in women undergoing hysterectomy for abnormal uterine bleeding, pelvic pain or uterine prolapse–A retrospective cohort study

H Krentel, RL De Wilde - Annals of Medicine and Surgery, 2022 - Elsevier
Background Adenomyosis can cause symptoms like dysmenorrhea, dyspareunia, pelvic
pain and bleeding disorders and is related to subfertility and obstetrical complications. The …

[HTML][HTML] Functional implications of estrogen and progesterone receptors expression in adenomyosis, potential targets for endocrinological therapy

M Sztachelska, D Ponikwicka-Tyszko… - Journal of clinical …, 2022 - mdpi.com
Adenomyosis is a common gynaecological disease associated with the presence of
endometrial lesions in the uterine myometrium. Estrogens have been proven to be the …

[HTML][HTML] An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis

H Zhang, BB Cao, J Tong, J Guo, J Zheng, L Zhu… - BMC Women's …, 2022 - Springer
Background Placement of a levonorgestrel-releasing intrauterine system (LNG-IUS) is an
effective treatment for adenomyosis, especially for patients who have severe dysmenorrhea …

[HTML][HTML] Transcutaneous electrical neurostimulation relieves primary dysmenorrhea: A randomized, double-blind clinical study versus placebo

M Guy, C Foucher, C Juhel, F Rigaudier, G Mayeux… - Progrès en urologie, 2022 - Elsevier
Introduction This randomized, crossover, double-blind, controlled trial evaluates the efficacy
and safety of a preprogrammed transcutaneous electrical nerve stimulation (TENS) device …

[Retracted] Clinical Efficacy of Dienogest versus Levonorgestrel‐Releasing Intrauterine System for Adenomyosis

S Yang, Y Liu, J Wen, Y Sun… - … Based Complementary and …, 2022 - Wiley Online Library
Objective. The aim of this study is to evaluate the efficacy of dienogest versus levonorgestrel‐
releasing intrauterine system (LNG‐IUS) for the treatment of adenomyosis. Methods. In this …

[HTML][HTML] Clinical practice guidelines for endometriosis in Japan (The 3rd edition)

T Harada, F Taniguchi, M Kitajima… - The Journal of …, 2022 - ncbi.nlm.nih.gov
More than 10 years following the publication of “The General Rules for Clinical Management
of Endometriosis: The second edition” in January 2010, the longawaited third edition has …

[HTML][HTML] Applying contrast-enhanced ultrasound model to distinguish atypical focal adenomyosis from uterine leiomyomas

YQ Zhang, JH Chen, TT Zhu, AX Zhao… - Annals of …, 2022 - ncbi.nlm.nih.gov
Background Different from conventional ultrasound, contrast-enhanced ultrasound (CEUS)
is better in observing microperfusion. For atypical focal adenomyosis and uterine …